4//SEC Filing
HENNEMAN JOHN B III 4
Accession 0001104659-25-057815
CIK 0001781983other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:05 PM ET
Size
7.4 KB
Accession
0001104659-25-057815
Insider Transaction Report
Form 4
HENNEMAN JOHN B III
Director
Transactions
- Award
Common Stock
2025-06-05+1,045→ 10,229 total - Award
Stock Options (Right to Buy)
2025-06-05+4,185→ 4,185 totalExercise: $1.81Exp: 2035-06-05→ Common Stock (4,185 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units which were granted on June 5, 2025, and which will vest and be settled in common stock on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
- [F2]The option vests in full on June 5, 2026, subject to the reporting person's continued service on the Issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
Documents
Issuer
Aprea Therapeutics, Inc.
CIK 0001781983
Entity typeother
Related Parties
1- filerCIK 0001187572
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:05 PM ET
- Size
- 7.4 KB